QUESTCOR PHARMACEUTICALS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 47 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-12-19: Reporting owner BAILEY DON M; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-19: Reporting owner BAILEY DON M; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-12-19: Reporting owner BAILEY DON M; Form 4; Security Stock Option (right to buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2012-10-11: Reporting owner FARRELL STEPHEN C; Form 4; Security Stock Option (right to purchase); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-12-19 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 373,339 owned after | $5.09 exercise price | 2012-12-21 | |
| 2012-12-19 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 353,339 owned after | $5.09 exercise price | 2012-12-21 | |
| 2012-12-19 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 333,339 owned after | $5.09 exercise price | 2012-12-21 | |
| 2012-10-11 | FARRELL STEPHEN C Director | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 2,500 owned after | $4.75 exercise price | 2012-10-15 | |
| 2012-10-11 | THOMPSON VIRGIL D Director | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $4.75 exercise price | 2012-10-15 | |
| 2012-10-11 | THOMPSON VIRGIL D Director | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,500 0 owned after | $5.12 exercise price | 2012-10-15 | |
| 2012-09-13 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −28,077 405,262 owned after | $5.09 exercise price | 2012-09-17 | |
| 2012-09-13 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,923 393,339 owned after | $5.09 exercise price | 2012-09-17 | |
| 2012-09-04 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −4,885 0 owned after | $10.16 exercise price | 2012-09-06 | |
| 2012-09-04 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −2,083 11,459 owned after | $10.16 exercise price | 2012-09-06 | |
| 2012-09-04 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −7,762 2,238 owned after | $14.73 exercise price | 2012-09-06 | |
| 2012-08-27 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 453,339 owned after | $5.09 exercise price | 2012-08-28 | |
| 2012-08-27 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −20,000 433,339 owned after | $5.09 exercise price | 2012-08-28 | |
| 2012-08-10 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −625 0 owned after | $1.47 exercise price | 2012-08-14 | |
| 2012-08-10 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,000 195,000 owned after | $4.54 exercise price | 2012-08-14 | |
| 2012-07-27 | FARRELL STEPHEN C Director | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,750 0 owned after | $4.45 exercise price | 2012-07-31 | |
| 2012-07-27 | FARRELL STEPHEN C Director | 4 | Stock Option (right to purchase) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,000 5,000 owned after | $4.45 exercise price | 2012-07-31 | |
| 2012-07-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,339 0 owned after | $0.44 exercise price | 2012-07-12 | |
| 2012-07-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −26,661 473,339 owned after | $5.09 exercise price | 2012-07-12 | |
| 2012-06-11 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 3,339 owned after | $0.44 exercise price | 2012-06-13 | |
| 2012-05-10 | THOMPSON VIRGIL D Director | 4/A | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +17,704 17,704 owned after | $40.37 exercise price | 2012-06-14 | |
| 2012-05-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 33,339 owned after | $0.44 exercise price | 2012-05-14 | |
| 2012-05-10 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,214 15,214 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-10 | Whitcup Scott M Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +3,803 3,803 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-10 | THOMPSON VIRGIL D Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,214 15,214 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-10 | FARRELL STEPHEN C Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,214 15,214 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-10 | BRADSHER NEAL C Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,214 290,214 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-10 | SILVERMAN LOU Director | 4 | Stock Option (right to purchase) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,214 15,214 owned after | $40.37 exercise price | 2012-05-14 | |
| 2012-05-04 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −11,458 13,542 owned after | $10.16 exercise price | 2012-05-07 | |
| 2012-05-04 | BLUTT MITCHELL J MD Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −115 4,885 owned after | $10.16 exercise price | 2012-05-07 | |
| 2012-04-27 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −70,000 205,000 owned after | $4.54 exercise price | 2012-05-01 | |
| 2012-04-19 | FARRELL STEPHEN C Director | 4 | Stock Option (right to buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −25,000 0 owned after | $1.92 exercise price | 2012-04-23 | |
| 2012-04-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (right to buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 63,339 owned after | $0.44 exercise price | 2012-04-12 | |
| 2012-03-09 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 93,339 owned after | $0.44 exercise price | 2012-03-13 | |
| 2012-02-15 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +250,000 250,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +125,000 125,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Cartt Stephen LaHue Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Cartt Stephen LaHue Officer (Chief Operating Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +45,000 45,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Mulroy Michael H. Officer (Sr VP, CFO & General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Mulroy Michael H. Officer (Sr VP, CFO & General Counsel) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +90,000 90,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Young David Officer (Chief Scientific Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Whitcup Scott M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +22,396 22,396 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Medeiros David Jeffrey Officer (EVP and CTO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +60,000 60,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-15 | Medeiros David Jeffrey Officer (EVP and CTO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $35.78 exercise price | 2012-02-17 | |
| 2012-02-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 123,339 owned after | $0.44 exercise price | 2012-02-14 | |
| 2012-01-10 | BAILEY DON M Director, Officer (President & CEO) | 4 | Stock Option (Right to Buy) Derivative · Indirect · Held by the Bailey 1995 Family Trust | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −30,000 153,339 owned after | $0.44 exercise price | 2012-01-12 |